Statement to State of the Union Address

WASHINGTON, D.C. (February 13, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:

PhRMA and EFPIA Applaud Push for EU-US Trade Agreement

Washington, D.C. and Brussels (February 12, 2013) —The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) welcome today’s announcement of a new trade agreement that will strengthen economic ties between Europe and the United States.

What’s on Your CEO’s Mind? Dr. John Lechleiter To Deliver Xavier University Keynote Address

02.12.13 By Jenni Brewer 

Xavier University, Cincinnati

Medicine’s Role in Strengthening Medicare

02.12.13 | By

With Medicare likely to be a leading topic in tonight’s State of the Union address, it’s clear that a new conversation over how best to reduce health care spending is underway. Regardless of political party, all sides agree that Medicare can be more sustainable while ensuring that seniors have regular access to the high-quality health care that they need. Medicare Part D, which covers more than 40 million seniors and persons with disabilities, plays a critical role in providing this care and reducing Medicare spending.

Medicine's Role in Strengthening Medicare

02.12.13 | By

With Medicare likely to be a leading topic in tonight's State of the Union address, it's clear that a new conversation over how best to reduce health care spending is underway. Regardless of political party, all sides agree that Medicare can be more sustainable while ensuring that seniors have regular access to the high-quality health care that they need. Medicare Part D, which covers more than 40 million seniors and persons with disabilities, plays a critical role in providing this care and reducing Medicare spending.

PhRMA Code on Interactions - External Verifications

PhRMA Code on Interactions with Healthcare Professionals External Verifications

PhRMA Code on Interactions with Healthcare Professionals - Signatory Companies

PhRMA Statement on Clinical Trials and Bad Pharma

WASHINGTON, D.C. (February 4, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President Josie Martin issued the following statement today:

PhRMA Chairman Lechleiter on the “Renaissance” of Biopharma Innovation

01.28.13 By Karl Uhlendorf

Pages

Subscribe to RSS - Opinion